Bisphosphonates suppress insulin‐like growth factor 1‐induced angiogenesis via the HIF‐1α/VEGF signaling pathways in human breast cancer cells
Vascular Endothelial Growth Factor A
0301 basic medicine
protein synthesis
nitrogen
Phosphatidylinositol 3-Kinases
Breast cancer
0302 clinical medicine
dose response
phosphatidylinositol 3 kinase
Insulin-Like Growth Factor I
VEGF MeSH: Base Sequence
Tumor
Diphosphonates
Neovascularization, Pathologic
messenger RNA
Reverse Transcriptase Polymerase Chain Reaction
TOR Serine-Threonine Kinases
Bisphosphonates
Immunohistochemistry
3. Good health
Author keywords: Angiogenesis
priority journal
IGF-1
protein degradation
Hypoxia-Inducible Factor 1
carcinogenesis
Signal Transduction
pamidronic acid
HIF-1α
610
Breast Neoplasms
Enzyme-Linked Immunosorbent Assay
alpha Subunit
Vascular Endothelial Growth Factor A EMTREE drug terms: clodronic acid
vasculotropin EMTREE medical terms: article
Cell Line
03 medical and health sciences
Cell Line, Tumor
Humans
controlled study
hypoxia inducible factor 1alpha
human
drug inhibition
protein expression
Neovascularization
mammalian target of rapamycin
DNA Primers
Pathologic
Base Sequence
human cell
Hypoxia-Inducible Factor 1, alpha Subunit
somatomedin C
Dentistry
protein kinase B beta
PI-3K/Akt
Protein Kinases
Proto-Oncogene Proteins c-akt
DOI:
10.1002/ijc.24710
Publication Date:
2009-06-30T16:31:32Z
AUTHORS (8)
ABSTRACT
Abstract Adjunctive chemotherapy with bisphosphonates has been reported to delay bone metastasis and improve overall survival in breast cancer. Aside from its antiresorptive effect, exhibit antitumor activities, vitro vivo , via several mechanisms, including antiangiogenesis. In this study, we investigated the potential molecular mechanisms underlying antiangiogenic effect of non–nitrogen‐containing nitrogen‐containing bisphosphonates, clodronate pamidronate, respectively, insulin‐like growth factor (IGF)‐1 responsive human cancer cells. We tested whether had any effects on hypoxia‐inducible (HIF)‐1α/vascular endothelial (VEGF) axis that plays a pivotal role tumor angiogenesis, our results showed both pamidronate significantly suppressed IGF‐1‐induced HIF‐1α protein accumulation VEGF expression MCF‐7 Mechanistically, found either or did not affect mRNA HIF‐1α, but they apparently promoted degradation protein. Meanwhile, presence led dose‐dependent decease newly‐synthesized induced by IGF‐1 cells after proteasomal inhibition, thus, indirectly reflecting inhibition synthesis. addition, indicated inhibitory HIF‐1α/VEGF are associated phosphoinositide 3‐kinase/AKT/mammalian target rapamycin signaling pathways. Consistently, demonstrated functionally abrogated angiogenesis IGF‐1‐stimulated These findings have highlighted an important mechanism pharmacological action
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (72)
CITATIONS (72)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....